| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Director | Restricted Stock Units | 121K | $395K | $4.01 | Nov 21, 2025 | Direct |
| Avidity Biosciences, Inc. | Director | Common Stock | 6.69K | $196K | $29.33 | Jun 10, 2025 | Direct |
| CATALYST PHARMACEUTICALS, INC. | Director | Common Stock, par value $0.001 per share | 2.36K | $50.6K | $21.43 | Nov 21, 2025 | Direct |
| CATALYST PHARMACEUTICALS, INC. | Director | Options to purchase common stock | 117K | Nov 20, 2025 | Direct | ||
| Avidity Biosciences, Inc. | Director | Stock Option (Right to Buy) | 10K | Jun 10, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CPRX | CATALYST PHARMACEUTICALS, INC. | Nov 20, 2025 | 4 | $0 | 4 | Nov 24, 2025 | Director |
| RNA | Avidity Biosciences, Inc. | Jun 10, 2025 | 2 | $0 | 4 | Jun 12, 2025 | Director |
| CPRX | CATALYST PHARMACEUTICALS, INC. | Dec 9, 2024 | 2 | $0 | 4 | Dec 11, 2024 | Director |
| CPRX | CATALYST PHARMACEUTICALS, INC. | Nov 21, 2024 | 2 | $0 | 4 | Nov 25, 2024 | Director |
| RNA | Avidity Biosciences, Inc. | Oct 7, 2024 | 3 | -$520K | 4 | Oct 9, 2024 | Director |
| RNA | Avidity Biosciences, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
| CPRX | CATALYST PHARMACEUTICALS, INC. | Dec 8, 2023 | 2 | $0 | 4 | Dec 12, 2023 | Director |
| RNA | Avidity Biosciences, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
| CPRX | CATALYST PHARMACEUTICALS, INC. | May 25, 2023 | 0 | $0 | 3 | Jun 5, 2023 | Director |
| RNA | Avidity Biosciences, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |